Mani, A., Roda, J., Young, D., Caligiuri, M. A., Fleming, G. F., Kaufman, P., . . . Shapiro, C. L. (2008). A phase II trial of trastuzumab in combination with low-dose interleukin-2 (IL-2) in patients (PTS) with metastatic breast cancer (MBC) who have previously failed trastuzumab.
Citación estilo ChicagoMani, Aruna, et al. A Phase II Trial of Trastuzumab in Combination With Low-dose Interleukin-2 (IL-2) in Patients (PTS) With Metastatic Breast Cancer (MBC) Who Have Previously Failed Trastuzumab. 2008.
Cita MLAMani, Aruna, et al. A Phase II Trial of Trastuzumab in Combination With Low-dose Interleukin-2 (IL-2) in Patients (PTS) With Metastatic Breast Cancer (MBC) Who Have Previously Failed Trastuzumab. 2008.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.